Digestive & Intestinal Remedies (Pharmacies) - Algeria

  • Algeria
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$64.53m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.12%, resulting in a market volume of US$68.22m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.39 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Algeria is experiencing steady growth due to several factors.

Customer preferences:
Algerian consumers are increasingly concerned about their digestive health and are actively seeking remedies to alleviate digestive discomfort. This is driven by changing dietary habits, such as the consumption of processed foods and a lack of fiber in the diet. Additionally, the growing awareness of the importance of gut health and its impact on overall well-being has led to an increased demand for digestive and intestinal remedies.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Algeria is the rising popularity of natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of synthetic medications and are opting for natural alternatives. This trend is also influenced by the cultural preference for traditional medicine in Algeria. As a result, there is a growing demand for herbal supplements and traditional remedies that are believed to have digestive benefits. Another trend in the market is the increasing availability of over-the-counter (OTC) digestive remedies in pharmacies. Previously, many of these products were only available through prescription, but the regulatory environment has evolved to allow easier access to OTC medications. This has made it more convenient for consumers to purchase digestive remedies without the need for a doctor's visit, leading to increased sales in pharmacies.

Local special circumstances:
Algeria has a large young population, with a significant proportion of the population under the age of 30. This demographic group is more likely to experience digestive issues due to their lifestyle and dietary choices. The demand for digestive and intestinal remedies is therefore driven by the specific needs of this age group. Additionally, the high prevalence of gastrointestinal diseases in Algeria, such as irritable bowel syndrome and gastritis, contributes to the demand for remedies in the market.

Underlying macroeconomic factors:
Algeria's healthcare sector has been undergoing significant development in recent years, with increased investment in infrastructure and healthcare services. This has resulted in improved access to healthcare facilities, including pharmacies, and has contributed to the growth of the Digestive & Intestinal Remedies market. Additionally, the rising disposable income of Algerian consumers has made healthcare products more affordable and accessible, further driving market growth. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Algeria is growing due to increasing customer preferences for natural remedies, the availability of OTC medications, the specific needs of the young population, and the overall development of the healthcare sector. These factors, along with the underlying macroeconomic factors, are contributing to the steady growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)